You are viewing: China Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The China Latent TB Testing Market was valued at $94.72 Million in 2024 and projected to reach to $143.05 Million by 2029, representing a compound annual growth rate of 8.6%. China's latent TB testing market is positioned for sustained expansion through 2029, driven by government-backed TB control programs and increased healthcare spending.

China Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Latent TB Testing Market Trends and Insights

  • This expansion reflects China's strengthened commitment to tuberculosis control and increased healthcare infrastructure investment across urban and rural regions.
  • China's rising prevalence of latent TB infections, combined with enhanced screening programs in high-risk populations, is driving demand for advanced diagnostic technologies. The market in China is benefiting from government-backed TB elimination initiatives and improved access to interferon-gamma release assays (IGRAs) and tuberculin skin tests.
  • China's healthcare modernization efforts and growing awareness among healthcare providers are accelerating adoption of latent TB testing solutions.
  • By 2029, China is expected to solidify its position as a key market within Asia Pacific, driven by regulatory support and expanded reimbursement policies that make testing more accessible to vulnerable populations..

Key Market Statistics

  • CAGR (2024-2029) 8.6% CAGR
  • Market Size, 2024 ~USD 94.72 Million
  • Forecast, 2029 ~USD 143.05 Million
  • Country China

China Latent TB Testing Market Overview

Market Valuation & Growth :

China's latent TB testing market reached $94.72 million in 2024 and is projected to grow to $143.05 million by 2029, representing a robust CAGR of 8.6%, significantly outpacing the global average of 5.8%.

Government TB Control Initiatives :

China's strengthened commitment to tuberculosis elimination through national screening programs and enhanced diagnostic infrastructure has accelerated latent TB testing adoption across both urban and rural healthcare facilities.

Healthcare Infrastructure Expansion :

Significant investment in healthcare infrastructure modernization, particularly in rural regions, has improved access to latent TB testing services and diagnostic capabilities throughout the country.

Rising Disease Prevalence :

Increasing prevalence of latent TB infections in China's population, combined with improved disease awareness and screening protocols, is driving demand for advanced testing solutions and diagnostic services.

China Latent TB Testing Market Dynamics

  • The country's focus on early detection and prevention aligns with WHO tuberculosis elimination targets, creating favorable conditions for market growth.
  • Urban centers are leading adoption, while rural healthcare modernization presents significant growth opportunities. The market will benefit from technological advancements in diagnostic testing, increased clinical awareness among healthcare providers, and expanded screening programs in high-risk populations.
  • Strategic partnerships between government health agencies and diagnostic manufacturers will further accelerate market penetration, supporting China's broader public health objectives..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • China's latent TB testing market is valued at $94.72 million in 2024 and will reach $143.05 million by 2029, representing an 8.6% CAGR.
    • Government-backed TB elimination programs and healthcare infrastructure expansion are primary growth catalysts in China.
    • China's increasing adoption of advanced diagnostic technologies like IGRAs is reshaping the latent TB testing landscape.
    • Expanded reimbursement policies and rural healthcare initiatives are broadening market accessibility across China.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    China Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    CHINA: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES5.476.436.727.077.528.058.689.417
    DIAGNOSTIC LABORATORIES50.0960.2364.2369.0474.9681.9690.2399.89.2
    HOSPITALS & CLINICS15.7918.6819.620.7322.1623.8525.8528.157.5
    OTHER END USERS3.434.024.184.374.634.935.295.76.4
    TOTAL74.7889.3694.72101.22109.26118.78130.05143.058.6

    Target Audience

    • Diagnostic Equipment Manufacturers : Need market sizing and growth projections for China to plan manufacturing capacity, distribution networks, and product localization strategies for latent TB testing devices.
    • Healthcare System Administrators : Require insights into market trends and government TB control initiatives to optimize screening program budgets, procurement decisions, and resource allocation across facilities.
    • In Vitro Diagnostics Companies : Seek detailed China market analysis to identify commercial opportunities, competitive positioning, and regulatory pathways for latent TB testing assays and reagents.
    • Investment & Private Equity Firms : Need comprehensive market data and growth forecasts for China to evaluate investment opportunities in TB diagnostics companies and healthcare infrastructure projects.
    • Public Health Policy Makers : Require market intelligence on testing adoption rates and infrastructure gaps in China to inform TB elimination strategy, funding allocation, and program effectiveness monitoring.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for China's latent TB testing sector with verified CAGR of 8.6% through 2029, enabling accurate financial forecasting and investment decision-making.
    • Regional Expansion Strategy : Identify high-growth opportunities across urban and rural China with detailed insights into healthcare infrastructure development and regional screening program implementation patterns.
    • Competitive Landscape Intelligence : Understand market dynamics specific to China, including government initiatives, regulatory environment, and key stakeholder strategies to inform market entry and positioning decisions.
    • Risk Assessment & Mitigation : Evaluate market drivers, disease prevalence trends, and policy changes affecting latent TB testing adoption in China to develop robust business continuity and growth strategies.
    • Stakeholder Alignment : Access China-specific data on healthcare provider adoption, patient screening behaviors, and government TB control priorities to align product development and marketing initiatives.

    Frequently asked questions

    What is the current size of China's latent TB testing market?

    China's latent TB testing market was valued at $94.72 million in 2024 and is projected to grow to $143.05 million by 2029.

    What is the expected growth rate for latent TB testing in China?

    China's latent TB testing market is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2029.

    What are the main drivers of growth in China's latent TB testing market?

    Key drivers include government TB elimination initiatives, healthcare infrastructure modernization, increased screening in high-risk populations, and expanded reimbursement policies in China.

    Which diagnostic technologies are most commonly used for latent TB testing in China?

    China primarily utilizes interferon-gamma release assays (IGRAs) and tuberculin skin tests, with IGRAs gaining increased adoption due to improved accuracy and accessibility.

    How is China's latent TB testing market positioned within Asia Pacific?

    China represents a significant growth market within Asia Pacific, driven by its large population, government support for TB control, and rapid healthcare modernization efforts.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status